ReviewFrontiers in immunology2023

Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review.

Hao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.